Literature DB >> 30302632

Expression, Purification, and Characterization of Recombinant Human α1-Antitrypsin Produced Using Silkworm-Baculovirus Expression System.

Yoshiki Morifuji1, Jian Xu2, Noriko Karasaki1, Kazuhiro Iiyama3, Daisuke Morokuma1, Masato Hino1, Akitsu Masuda1, Takumi Yano1, Hiroaki Mon1, Takahiro Kusakabe1, Jae Man Lee4.   

Abstract

Human α1-antitrypsin (AAT) is the most abundant serine proteinase inhibitor (serpin) in the human plasma. Commercially available AAT for the medications of deficiency of α1-antitrypsin is mainly purified from human plasma. There is a high demand for a stable and low-cost supply of recombinant AAT (rAAT). In this study, the baculovirus expression vector system using silkworm larvae as host was employed and a large amount of highly active AAT was recovered from the silkworm serum (~ 15 mg/10 ml) with high purity. Both the enzymatic activity and stability of purified rAAT were comparable with those of commercial product. Our results provide an alternative method for mass production of the active rAAT in pharmaceutical use.

Entities:  

Keywords:  Baculovirus expression vector system; Recombinant protein; Serpin; Silkworm; α1-Antitrypsin

Mesh:

Substances:

Year:  2018        PMID: 30302632     DOI: 10.1007/s12033-018-0127-y

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  30 in total

1.  Mass Production of an Active Peptide-N-Glycosidase F Using Silkworm-Baculovirus Expression System.

Authors:  Atsushi Masuda; Jian Xu; Takumi Mitsudome; Yudai Nagata; Daisuke Morokuma; Hiroaki Mon; Yutaka Banno; Takahiro Kusakabe; Jae Man Lee
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

2.  Features of the milk whey protein partitioning in polyethyleneglycol-sodium citrate aqueous two-phase systems with the goal of isolating human alpha-1 antitrypsin expressed in bovine milk.

Authors:  Andrea Boaglio; Georgina Bassani; Guillermo Picó; Bibiana Nerli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-04-27       Impact factor: 3.205

3.  Genetic modification of a baculovirus vector for increased expression in insect cells.

Authors:  Richard B Hitchman; Robert D Possee; Andrew T Crombie; Adam Chambers; Kim Ho; Evangelia Siaterli; Olga Lissina; Heather Sternard; Robert Novy; Kathryn Loomis; Louise E Bird; Raymond J Owens; Linda A King
Journal:  Cell Biol Toxicol       Date:  2009-08-05       Impact factor: 6.691

4.  N-glycan analysis of human α1-antitrypsin produced in Chinese hamster ovary cells.

Authors:  Kyung Jin Lee; Sang Mee Lee; Jin Young Gil; Ohsuk Kwon; Jin Young Kim; Soon Jae Park; Hye-Shin Chung; Doo-Byoung Oh
Journal:  Glycoconj J       Date:  2012-10-12       Impact factor: 2.916

5.  Expression and characterization of recombinant human alpha-antitrypsin in transgenic rice seed.

Authors:  Liping Zhang; Jingni Shi; Daiming Jiang; Jacek Stupak; Jiquan Ou; Qichuan Qiu; Na An; Jianjun Li; Daichang Yang
Journal:  J Biotechnol       Date:  2013-01-31       Impact factor: 3.307

6.  Improved expression of fusion protein using a cysteine- protease- and chitinase-deficient Bombyx mori (silkworm) multiple nucleopolyhedrovirus bacmid in silkworm larvae.

Authors:  Enoch Y Park; Takahiro Abe; Tatsuya Kato
Journal:  Biotechnol Appl Biochem       Date:  2008-02       Impact factor: 2.431

7.  Expression, purification, and characterization of endo-β-N-acetylglucosaminidase H using baculovirus-mediated silkworm protein expression system.

Authors:  Takumi Mitsudome; Jian Xu; Yudai Nagata; Atsushi Masuda; Kazuhiro Iiyama; Daisuke Morokuma; Zhiqing Li; Hiroaki Mon; Jae Man Lee; Takahiro Kusakabe
Journal:  Appl Biochem Biotechnol       Date:  2014-03-06       Impact factor: 2.926

8.  Expression, purification and characterization of recombinant Z alpha(1)-antitrypsin--the most common cause of alpha(1)-antitrypsin deficiency.

Authors:  Vita Levina; Weiwen Dai; Anja S Knaupp; Dion Kaiserman; Mary C Pearce; Lisa D Cabrita; Phillip I Bird; Stephen P Bottomley
Journal:  Protein Expr Purif       Date:  2009-06-23       Impact factor: 1.650

9.  Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.

Authors:  Simone A Glynn; Michael P Busch; Roger Y Dodd; Louis M Katz; Susan L Stramer; Harvey G Klein; Graham Simmons; Steven H Kleinman; Susan B Shurin
Journal:  Transfusion       Date:  2012-06-13       Impact factor: 3.157

10.  Expression and Purification of Functionally Active Recombinant Human Alpha 1-Antitrypsin in Methylotrophic Yeast Pichia pastoris.

Authors:  Sareh Arjmand; Elham Bidram; Abbas Sahebghadam Lotfi; Mehdi Shamsara; Seyed Javad Mowla
Journal:  Avicenna J Med Biotechnol       Date:  2011-07
View more
  2 in total

1.  Expression and Purification of Vaccinia Virus DNA Topoisomerase IB Produced in the Silkworm-Baculovirus Expression System.

Authors:  Jian Xu; Jae Man Lee; Tuneyuki Tatsuke; Takeru Ebihara; Akitsu Masuda; Masato Hino; Daisuke Morokuma; Ryosuke Fujita; Hiroaki Mon; Takahiro Kusakabe; Masateru Takahashi
Journal:  Mol Biotechnol       Date:  2019-08       Impact factor: 2.860

2.  Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System.

Authors:  Takeru Ebihara; Akitsu Masuda; Daisuke Takahashi; Masato Hino; Hiroaki Mon; Kohei Kakino; Tsuguru Fujii; Ryosuke Fujita; Tadashi Ueda; Jae Man Lee; Takahiro Kusakabe
Journal:  Mol Biotechnol       Date:  2021-07-25       Impact factor: 2.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.